Total Payments
$8,270
2024 Payments
$13.73
Companies
33
Transactions
221
Medicare Patients
797
Medicare Billing
$71,460
Payment Breakdown by Category
Food & Beverage$8,108 (98.0%)
Education$102.80 (1.2%)
Gifts$59.40 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,108 | 212 | 98.0% |
| Education | $102.80 | 8 | 1.2% |
| Gift | $59.40 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,386 | 26 | $0 (2021) |
| GlaxoSmithKline, LLC. | $1,344 | 27 | $0 (2024) |
| Amarin Pharma Inc. | $686.92 | 20 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $560.87 | 13 | $0 (2019) |
| Lilly USA, LLC | $475.71 | 20 | $0 (2022) |
| Novo Nordisk Inc | $459.33 | 10 | $0 (2019) |
| Allergan, Inc. | $402.14 | 15 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $374.93 | 10 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $355.43 | 17 | $0 (2021) |
| Abbott Laboratories | $277.08 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.73 | 1 | GlaxoSmithKline, LLC. ($13.73) |
| 2023 | $93.38 | 1 | GlaxoSmithKline, LLC. ($93.38) |
| 2022 | $421.49 | 5 | GlaxoSmithKline, LLC. ($238.71) |
| 2021 | $301.08 | 7 | GlaxoSmithKline, LLC. ($139.86) |
| 2020 | $573.42 | 14 | AstraZeneca Pharmaceuticals LP ($282.02) |
| 2019 | $1,644 | 53 | Amarin Pharma Inc. ($307.38) |
| 2018 | $2,763 | 75 | AstraZeneca Pharmaceuticals LP ($509.04) |
| 2017 | $2,460 | 65 | AstraZeneca Pharmaceuticals LP ($467.21) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $93.38 | General |
| 06/24/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Diabetes | ||||||
| 06/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $118.72 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $119.99 | General |
| Category: RESPIRATORY | ||||||
| 03/15/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $106.95 | General |
| Category: DIABETES MEDICINE | ||||||
| 02/01/2022 | Mannkind Corporation | AFREZZA (Drug) | Gift | In-kind items and services | $59.40 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/01/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $119.29 | General |
| Category: RESPIRATORY | ||||||
| 10/06/2021 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: Cardiovascular | ||||||
| 09/21/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $107.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/16/2021 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: RESPIRATORY | ||||||
| 02/05/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: NEUROSCIENCE | ||||||
| 01/29/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.59 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: UROLOGY | ||||||
| 06/26/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: NEUROSCIENCE | ||||||
| 06/17/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Diabetes | ||||||
| 05/12/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Endocrinology | ||||||
| 03/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: RESPIRATORY | ||||||
| 03/12/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2020 | Takeda Pharmaceuticals U.S.A., Inc. | AMITIZA (Drug) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/19/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Endocrinology | ||||||
| 02/11/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 108 | 144 | $20,725 | $12,942 |
| 2022 | 4 | 161 | 226 | $29,775 | $17,479 |
| 2021 | 5 | 224 | 292 | $37,300 | $19,991 |
| 2020 | 6 | 304 | 360 | $45,500 | $21,048 |
Total Patients
797
Total Services
1,022
Medicare Billing
$71,460
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 40 | 40 | $8,000 | $5,275 | 65.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 73 | $7,300 | $5,111 | 70.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 29 | 31 | $5,425 | $2,556 | 47.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 109 | $10,900 | $7,303 | 67.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 47 | 47 | $9,400 | $6,517 | 69.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 33 | $5,775 | $2,943 | 51.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 37 | 37 | $3,700 | $715.33 | 19.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 112 | $11,200 | $7,376 | 65.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $9,000 | $6,312 | 70.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 48 | $8,400 | $4,590 | 54.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 44 | 44 | $4,400 | $866.36 | 19.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 43 | 43 | $4,300 | $846.67 | 19.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 71 | 71 | $14,200 | $8,909 | 62.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 118 | $11,800 | $6,313 | 53.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 36 | $6,300 | $3,003 | 47.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2020 | 62 | 62 | $6,200 | $1,211 | 19.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 61 | 61 | $6,100 | $1,192 | 19.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 12 | $900.00 | $420.43 | 46.7% |
About Dr. Jose Baca, MD
Dr. Jose Baca, MD is a Internal Medicine healthcare provider based in Hialeah, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558308783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jose Baca, MD has received a total of $8,270 in payments from pharmaceutical and medical device companies, with $13.73 received in 2024. These payments were reported across 221 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,108).
As a Medicare-enrolled provider, Baca has provided services to 797 Medicare beneficiaries, totaling 1,022 services with total Medicare billing of $71,460. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Hialeah, FL
- Active Since 05/31/2006
- Last Updated 02/07/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558308783
Products in Payments
- FARXIGA (Drug) $864.82
- Vascepa (Drug) $686.92
- TRELEGY ELLIPTA (Drug) $567.62
- JARDIANCE (Drug) $478.99
- Tresiba (Drug) $388.75
- Mitra Clip system (Device) $277.08
- BYDUREON (Drug) $250.00
- Veltassa (Drug) $237.24
- ANORO (Drug) $235.48
- BREO (Drug) $216.91
- TRULICITY (Drug) $214.57
- INVOKANA (Drug) $200.87
- VIBERZI (Drug) $184.18
- XARELTO (Drug) $168.04
- AFREZZA (Drug) $166.35
- JANUVIA (Drug) $164.23
- Trintellix (Drug) $157.08
- BELSOMRA (Drug) $153.23
- SYMBICORT (Drug) $125.93
- BEVESPI AEROSPHERE (Drug) $125.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hialeah
Miguel Diaz, Md, MD
Internal Medicine — Payments: $472,891
Internal Medicine $472,891
Karelia Ruiz
Internal Medicine — Payments: $114,006
Internal Medicine $114,006
Dr. Francisco Rosas, M.d, M.D
Internal Medicine — Payments: $105,387
Internal Medicine $105,387
Dr. Miguel Perez, M.d, M.D
Internal Medicine — Payments: $86,695
Internal Medicine $86,695
Dr. William Sanchez, M.d, M.D
Internal Medicine — Payments: $16,197
Internal Medicine $16,197
Dr. Jorge Diaz, D.o, D.O
Internal Medicine — Payments: $15,027
Internal Medicine $15,027